One preliminary study suggests CBD may help to fight Covid-19
Further studies will be required to verify the research and facilitate the creation of CBD-centric solutions suitable for Covid-19 patients.
GW Pharmaceuticals’ cannabis-derived epilepsy drug wins European approval
The European Commission approved GW Pharma's Epidyolex as a treatment for seizures in two rare and severe forms of epilepsy. The drug won FDA approval last year.
Transforming the OR: CEO Reveals Game-Changing AI Tech for Better Efficiency
How Apella leverages technology to increase OR efficiency.
Sandoz gets into the weeds with cannabis medical product manufacturer Tilray
The Canadian company's shares reached a high price after it signed a framework agreement with Novartis's generics arm that would enable global commercialization.
GW Pharmaceuticals gets first FDA approval for CBD-based drug
The FDA approved the cannabis-based drug for treating seizures in two severe forms of epilepsy.
5 companies mixing medicine and marijuana
From eye drops for glaucoma to chewing gum for irritable bowel syndrome, derivatives of cannabis are making their way into FDA trials in pursuit of a biotech/pharma market projected to reach $20 billion by 2020.